COMMENTARY
Open Access

Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling

Moazzam Ali, Luis Bahamondes and Sihem Bent Landoulsi
Global Health: Science and Practice December 2017, 5(4):534-539; https://doi.org/10.9745/GHSP-D-17-00296
Submit a Comment to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson{at}gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

No comments have been published for this article.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
Moazzam Ali, Luis Bahamondes, Sihem Bent Landoulsi
Global Health: Science and Practice Dec 2017, 5 (4) 534-539; DOI: 10.9745/GHSP-D-17-00296
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Statistics from Altmetric.com

Jump to section

Subjects